State Street Corp Updates Passive Stake in Coherus BioSciences
Ticker: CHRS · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1512762
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street still owns Coherus stock, signaling continued institutional interest.**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Coherus BioSciences, Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, showing their continued passive investment in the biotechnology company. For investors, this means a significant institutional player maintains a position in Coherus, which can signal a degree of confidence in the stock, though the exact percentage of ownership is not provided in the excerpt.
Why It Matters
This filing confirms State Street Corp's ongoing institutional investment in Coherus BioSciences, which can influence investor sentiment and stock stability.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor, indicating a passive stake, which generally poses low risk.
Analyst Insight
Investors should note the continued institutional interest from State Street Corp, but also recognize this is a passive stake and does not necessarily signal an imminent major strategic move. Further research into Coherus BioSciences' fundamentals and other institutional holdings would be prudent.
Key Numbers
- 19249H103 — CUSIP Number (identifies Coherus BioSciences, Inc. common stock)
Key Players & Entities
- State Street Corp (company) — the reporting person and institutional investor
- Coherus BioSciences, Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- State Street Corp will maintain a passive investment in Coherus BioSciences for the foreseeable future. (State Street Corp) — medium confidence, target: 2025-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to a previously reported beneficial ownership statement.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORP, a financial institution with a Central Index Key (CIK) of 0000093751.
What is the subject company whose securities are being reported?
The subject company is Coherus BioSciences, Inc., identified by the CIK 0001512762 and CUSIP number 19249H103.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1 (B), as indicated by the 'X' next to the rule designation.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Coherus BioSciences, Inc. (CHRS).